Clinical Trial Update: Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo [Phase 4]

View source ↗

Summary

Phase 4 trial comparing raloxifene to placebo in postmenopausal osteoporosis assessed carotid artery intima-media thickness; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Raloxifene (raloxifene)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Post-Menopausal | Phase 4 | Status: COMPLETED